NCT05002374

Brief Summary

Background Patients with peripheral vestibular dysfunction often complain of dizziness, blurred vision, imbalance and etc. Vestibular rehabilitation although has been proved to be an efficient method to improve the symptoms, the optimal treatment type, intensity and frequency is still unclear. Base on the mechanisms of vestibular rehabilitation, vestibular adaptation, substitution, and habituation, repeated practice and exposure to symptom-provoked movement could improve the symptoms. However, the symptom-provoked movement generated by only head and eye movement might not create sufficient threshold to induce vestibulo-ocular reflex adaptation. Practicing vestibular exercises in the same environment might be difficult for the patients to transfer learned ability to the real world environment. Therefore, optokinetic stimulation could potentially provide stronger visual-vestibular mismatch, and when combining with a virtual reality system could also simulate real world environment. Furthermore, an intensive training protocol on a daily basis might possibly promote the mechanisms of vestibular rehabilitation to enhance recovery from peripheral vestibular lesions. The purpose of this study is to investigate the efficacy of an intense vestibular rehabilitation programme incorporated with optokinetic stimulation in virtual reality environment on both subjective and objective symptoms in patients with peripheral vestibular dysfunction in the short and long term. Methods This study will be an assessor-blind randomised controlled trial. Patients diagnosed as peripheral vestibular dysfunction aged between 20-80 years will be recruited and randomly allocated into two groups: vestibular rehabilitation incorporated with optokinetic stimulation in virtual reality (Group OKN) and vestibular rehabilitation only (Group C). Group C will receive customised vestibular rehabilitation, while Group OKN will receive the same exercise programme as Group C plus optokinetic stimulation provided in virtual environment. Both groups will receive vestibular rehabilitation intensively for five consecutive days with a trained physiotherapist, following with daily home exercise for two months. Self-perceived symptoms, spatial orientation, postural control and gait performance will be assessed prior to treatment (baseline), at the end of the five-day treatment, at four and eight weeks following the five-day training.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 22, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 12, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

October 25, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
Last Updated

November 27, 2023

Status Verified

November 1, 2023

Enrollment Period

2.7 years

First QC Date

July 22, 2021

Last Update Submit

November 23, 2023

Conditions

Outcome Measures

Primary Outcomes (8)

  • Subjective visual vertical test

    This test is to assess a person's perception of verticality. In this test, the subject is instructed to align a tilted illuminated line to self-perceived verticality in a completely darkened room. Differences between the subject's adjusted orientation and true spatial vertical are calculated as the subjective visual vertical.

    Before treatment

  • Subjective visual vertical test

    This test is to assess a person's perception of verticality. In this test, the subject is instructed to align a tilted illuminated line to self-perceived verticality in a completely darkened room. Differences between the subject's adjusted orientation and true spatial vertical are calculated as the subjective visual vertical.

    After the 5-day treatment

  • Subjective visual vertical test

    This test is to assess a person's perception of verticality. In this test, the subject is instructed to align a tilted illuminated line to self-perceived verticality in a completely darkened room. Differences between the subject's adjusted orientation and true spatial vertical are calculated as the subjective visual vertical.

    At four weeks after the treatment

  • Subjective visual vertical test

    This test is to assess a person's perception of verticality. In this test, the subject is instructed to align a tilted illuminated line to self-perceived verticality in a completely darkened room. Differences between the subject's adjusted orientation and true spatial vertical are calculated as the subjective visual vertical.

    At eight weeks after the treatment

  • Postural stability

    Standing postural stability under various conditions measured by a force platform

    Before treatment

  • Postural stability

    Standing postural stability under various conditions measured by a force platform

    After the 5-day treatment

  • Postural stability

    Standing postural stability under various conditions measured by a force platform

    At four weeks after the treatment

  • Postural stability

    Standing postural stability under various conditions measured by a force platform

    At eight weeks after the treatment

Secondary Outcomes (4)

  • The dizziness handicap inventory

    Prior and after the 5-day treatment, and follow up at four and eight weeks after the treatment

  • The vestibular disorders activities of daily living scale

    Prior and after the 5-day treatment, and follow up at four and eight weeks after the treatment

  • The hospital anxiety and depression scale

    Prior and after the 5-day treatment, and follow up at four and eight weeks after the treatment

  • Gait performance

    Prior and after the 5-day treatment, and follow up at four and eight weeks after the treatment

Study Arms (2)

Experimental Group

EXPERIMENTAL
Other: Vestibular rehabilitation with optokinetic stimulation

Control Group

ACTIVE COMPARATOR
Other: Vestibular rehabilitation

Interventions

Vestibular rehabilitation incorporated with optokinetic stimulation in virtual reality environment for five consecutive days

Experimental Group

Customized vestibular rehabilitation for five consecutive days

Control Group

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed as peripheral vestibular dysfunction with bithermal caloric irrigation
  • having one or more of the following subjective complains for longer than four weeks: vertigo/dizziness, disequilibrium, gait instability or motion sensitivity

You may not qualify if:

  • central nervous system involvement
  • active or poorly controlled migraine (more than one severe migraine a month)
  • fluctuating symptoms e.g. Meniere's disease
  • active benign paroxysmal positional vertigo (BPPV)
  • have previous vestibular rehabilitation
  • inability to attend sessions
  • other medical conditions in the acute phase e.g. orthopaedic injury

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physical Therapy

Tainan, 704, Taiwan

RECRUITING

Study Officials

  • Pei-Yun Lee, PhD

    National Cheng Kung University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

July 22, 2021

First Posted

August 12, 2021

Study Start

October 25, 2021

Primary Completion

July 1, 2024

Study Completion

July 1, 2024

Last Updated

November 27, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations